HARBRIGHT IN THE NEWS
Get the latest news here
FDA accepts CryoLife®‘s IDE application for clinical trials. Intended Use AMDS is intended for aortic repair, aortic remodeling, and re-expansion of the intimal flap within the ascending aorta, aortic arch, and into the descending…
The financing will be used to support the company’s continued scale, assist in the development of additional key features, and general corporate purposes. Private equity firm, Harbright Ventures, and early investor, Thomas Daly, have…
6AM will double the size of the company starting with the newsletter launch of NASHtoday (Nashville, TN) in March, to join 7 existing southeastern markets and 300,000+ subscribers. Greenville, S.C. (February 1, 2021) — 6AM City…
(CARY, NC – September 24, 2020) – Harbright Ventures, a Raleigh-Durham based early stage investment fund, today announced the exit and future distribution of $15 million to investors related to the portfolio investment in…
